Skip to main content

Table 1 Clinical laboratory data

From: Coexistence of pernicious anemia and prostate cancer - 'an experiment of nature' involving vitamin B12 modulation of prostate cancer growth and metabolism: a case report

 

18 October 2007 - Diagnosis prostate cancer

19 February 2008 - PSA progression

4 June 2008 - PSA progression

21 October 2008 - Diagnosis of PA

30 October 2008 - B12 Rx

10 November 2008 - B12 Rx

24 November 2008 - B12 Rx

Hb, g/dl

-

-

-

7.5

8.6

9.2

9.9

MCV, fl

-

-

-

124

122

117.7

113

Reticulocyte count, cells/μl

-

-

-

9500

23,230

11,450

7470

MMA, nM/l

-

-

-

13,970

3069

-

290

tHcy, μM/l

-

-

-

109

14

18.8

14.8

B12, pg/ml

-

-

-

32

>1500

>1500

>1500

holoTC, pg/ml

-

-

-

0

-

-

-

Testosterone, ng/dl

-

-

-

331

346

205

323

PSA, ng/ml

4.0

7.3

9.2

16.7

22.9

21.1

21.3

PAP, ng/ml

-

-

-

1.5

2.3

3.2

2.4

Folate, ng/ml

-

-

-

17.4

-

17.5

-

B12 injection, μg/day subcutaneous

-

-

-

1000

1000

1000

1000

  1. B12, cobalamin; Hb, haemoglobin; holoTC, holotranscobalamin; MMA, methylmalonic acid; PA, pernicious anemia; PAP, prostatic acid phosphatase; PSA, prostate specific antigen; Rx, treatment; tHcy, total homocysteine.